Clicky

Bionano Genomics Inc(2Y3)

Description: Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.


Keywords: Biotechnology Biology Molecular Biology Disorders Genomics Laboratory Services DNA DNA Sequencing Seizure Autism Spectrum Disorder Fragile X Syndrome DNA Chip Personal Genomics Exome Sequencing Infantile Spasms Encephalopathy Exome Genetic Mapping Reagents And Protocols Saphyr

Home Page: www.bionanogenomics.com

9540 Towne Centre Drive
San Diego, CA 92121
United States
Phone: 858 888 7600


Officers

Name Title
Dr. Robert Erik Holmlin M.B.A., Ph.D. Pres, CEO, Sec. & Director
Mr. Mark Oldakowski Chief Operating Officer
Mr. Christopher P. Stewart Chief Financial Officer
Mr. Mark Adamchak CPA VP of Accounting & Controller
Jonathan Dixon Global Head of Legal
Mr. Stanislas Marin M.B.A., M.S. Head of Global Sales
Ms. Helene Klein Chief People Officer
Dr. Alka Chaubey FACMG, Ph.D. Chief Medical Officer
Dr. Soheil Shams Ph.D. CIO of Emeritus
Ms. Donna Polizio Global Head of Market Access

Exchange: F

Country: DE

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.1427
Price-to-Sales TTM: 20.1008
IPO Date:
Fiscal Year End: December
Full Time Employees: 299
Back to stocks